SynAct Pharma AB

ABActive

Org 5590584826Scheelevägen 2, 223 63 LundResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2016 · 10 years old5-9 employees

Overview Financials People & ownership Related companies

SynAct Pharma AB is a Swedish AB based in Lund, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2016, the company reported revenue of SEK 6,8M in its latest annual filing.

Revenue 2025

SEK 6,8M

-2% vs 2024

EBITDA margin

-191.8%

+41% vs 2024

Net profit 2025

SEK -98,1M

-8% vs 2024

Key ratios

See full ratios →

94.0%

This company

20212025

15.0×

This company

20212025

-42.6%

This company

20212025

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK 6,8M	-2%
EBITDA	SEK -13,1M	+41%
Net profit	SEK -98,1M	-8%
Total assets	SEK 230,2M	-11%
Equity	SEK 216,3M	-10%
Employees	—	—

Frequently asked questions

What is the Org number of SynAct Pharma AB?

SynAct Pharma AB is registered with Bolagsverket / SCB under Org 5590584826.

What is the revenue of SynAct Pharma AB?

SynAct Pharma AB reported revenue of SEK 6,8M in 2025.

Who is the CEO of SynAct Pharma AB?

Jeppe Øvli Øvlesen is the CEO of SynAct Pharma AB, in role since 2024.

Who is the chairman of SynAct Pharma AB?

Anders Kronborg chairs the board of SynAct Pharma AB, in role since 2024.

Where is SynAct Pharma AB headquartered?

SynAct Pharma AB's registered address is Scheelevägen 2.

SynAct Pharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Frequently asked questions

More on SynAct Pharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Frequently asked questions

More on SynAct Pharma AB